miR-205 inhibits the expression of ACSL4 by targeting its 3′-UTR, and anti-miR-205 can accelerate lipogenesis through regulating ACSL4 in hepatoma cells (Cui et al., 2014). The gene discussed is ACSL4; the disease is hepatocellular carcinoma.